Diane Berson, MD talks to Joel L. Cohen, MD about current and investigational hormone inhibitors for the treatment of acne. She discusses the safety and efficacy of spironolactone for adult female patients, especially those who suffer from cyclical acne. She also discusses a new topical androgen receptor inhibitor that is currently being investigated for treating acne by reducing sebum production.
News | March 25, 2019
Biofrontera Inc., USA entered into an agreement to acquire all shares in Cutanea Life Sciences, Inc., USA through its subsidiary Biofrontera Newderm LLC as the acquirer, with Maruho Co., Ltd., Japan as the seller. Maruho holds approximately...
Every industry has its own vocabulary and script. In medicine, especially in dermatology training, the fundamentals start with vocabulary. Morphology, pathology, and physical exam findings all have unique descriptions and words that take...
Dermatologists and practice staff daily must surmount numerous administrative hurdles to help ensure that their patients receive recommended care and treatment and that the patient’s insurance plan covers what’s been prescribed....
Pivotal Phase 3 Trials of Trifarotene in Patients with Moderate Facial and Truncal Acne Meet All Efficacy Endpoints
Nestlé Enters into Negotiations to Sell Nestlé Skin Health to Consortium Led by EQT and ADIA
AAD Honors Dr. Robert Brodell for Establishing Free Clinic in the Mississippi Delta
Diane Berson, MD talks to Joel L. Cohen, MD about current and investigational hormone inhibitors for the treatment of acne. She discusses the safety...
Complaints and concerns abound, but remedies are slow in coming.
This is dedicated to our friends in pharma…and you know who you are.
Neal Bhatia, MD, FAAD
Calling All Students: Ortho Dermatologics Now Accepting Applications for the 2019 Aspire Higher Scholarship Program
After the acute treatment phase, experts urge a long-view on management.
The evidence is in: Mental well-being influences the skin.
Helen Taylor, PhD
Most patients will always remain acne-prone, but the right interventions can keep their skin healthy.
Nancy J. Samolitis, MD, FAAD